ANTIBODY-ENHANCED THROMBOLYSIS - TARGETING OF TISSUE PLASMINOGEN-ACTIVATOR INVIVO
ANTIBODY-ENHANCED THROMBOLYSIS - TARGETING OF TISSUE PLASMINOGEN-ACTIVATOR INVIVO
复制标题
DOI:
10.1073/pnas.84.21.7659
复制
发表时间:
1987-11-01
影响因子:
11.1
通讯作者:
HABER, E
中科院分区:
文献类型:
--
作者:
RUNGE, MS;BODE, C;HABER, E
Tissue plasminogen activator (tPA) was modified by the unidirectional crosslinking reagent N-succinimidyl 3-(2-pyridyldithio)propionate and coupled to iminothiolane-modified anti-fibrin antibody 59D8 by the formation of disulfide bonds at neutral pH. Purification by two affinity-chromatography steps yielded tPA-antifibrin antibody conjugate (tPA-59D8) possessing both tPA and anti-fibrin antibody activities. In a quantitative rabbit thrombolysis model, the activity of the purified conjugate was compared with that of tPA alone and that of a conjugate between tPA and a digoxin-specific monoclonal antibody. After correction for spontaneous lysis (10.9 .+-. 2.5%), tPA-59D8 was shown to be 2.8-9.6 times more potent than tPA alone. Unconjugated tPA and tPA-digoxin were equipotent. At equivalent thrombolytic concentrations, tPA-59D8 degraded less fibrinogen and consumed less .alpha.2-anti-plasmin than did tPA alone. This suggests that tPA can be efficiently directed to the site of a thrombus by conjugation to an anti-fibrin monoclonal antibody, resulting in both more potent and more selective thrombolysis.